Research
Thesis
Characterisation of platelet and microparticle phospholipids in thrombotic and bleeding disorders
Publications
2022
- Dixon, P. H. et al. 2022. GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nature Communications 13(1), article number: 4840. (10.1038/s41467-022-29931-z)
2021
- Collins, P. W., Obaji, S. G., Roberts, H., Gorsani, D. and Rayment, R. 2021. Clinical phenotype of severe and moderate haemophilia: who should receive prophylaxis and what is the target trough level?. Haemophilia 27(2), pp. 192-198. (10.1111/hae.14201)
2020
- Rosas, M. et al. 2020. The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles. PLoS ONE 15(10), article number: e0240189. (10.1371/journal.pone.0240189)
- Obaji, S. G. 2020. Characterisation of platelet phospholipids in unclassified bleeding disorders and deep vein thrombosis. PhD Thesis, Cardiff University.
2019
- Allen-Redpath, K. et al. 2019. Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity. Proceedings of the National Academy of Sciences 116(16), pp. 8038-8047. (10.1073/pnas.1814409116)
2018
- Westbury, S. K. et al. 2018. Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder. Blood Advances 2(18), pp. 2341-2346. (10.1182/bloodadvances.2018020370)
2017
- Lauder, S. N. et al. 2017. Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis. Science Signaling 10(507), article number: eaan2787. (10.1126/scisignal.aan2787)
- Pleines, I. et al. 2017. Mutations in tropomyosin 4 underlie a rare form of human macrothrombocytopenia. The Journal of Clinical Investigation 127(3), pp. 814-829. (10.1172/JCI86154)
2016
- Obaji, S., Alikhan, R., Rayment, R., Carter, P., Macartney, N. J. and Collins, P. W. 2016. Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin. Haemophilia 22(2), pp. 285-291. (10.1111/hae.12811)
2015
- Mahdi, A. J., Obaji, S. and Collins, P. W. 2015. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia. British Journal of Haematology 169(6), pp. 768-776. (10.1111/bjh.13360)
- Obaji, S., Jones, C., Yates, A., Gordon, A., Wood, A., Alikhan, R. and Collins, P. 2015. Selective angiographic embolization for recurrent elbow and knee haemarthroses in haemophilia: a retrospective case series. Haemophilia 21(3), pp. e226-e228. (10.1111/hae.12629)